Mapeo linfático y biopsia del ganglio centinela en pacientes con carcinoma epidermoide cutáneo de alto riesgo

Reséndiz-Colosia, Jaime Alonso; Valenzuela-Flores, Adriana Abigail; Torres-Nuñez, Guadalupe; Valenzuela-Flores, Alma Gabriela; Flores-Díaz, Rutilio; Gallegos-Hernández, Francisco José; Rodríguez-Cuevas, Sergio Arturo.
Gac. méd. Méx ; 143(3): 209-214, mayo-jun. 2007. tab
Artículo en Español | LILACS | ID: lil-568748

Documentos relacionados

  1. [The Cutaneous Squamous Cell Carcinoma - An Update].
  2. Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation.
  3. Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma.
  4. Evaluation of peritumoral inflammatory infiltration and its relationship with different prognostic factors in cutaneous squamous cell carcinoma.
  5. [Dermatology - Update on systemic treatments for locally advanced and/or metastatic cutaneous squamous cell carcinoma].
  6. Differentiation-related epigenomic changes define clinically distinct keratinocyte cancer subclasses.
  7. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells.
  8. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
  9. Pilonidal sinus disease carcinoma: Survival and recurrence analysis.
  10. Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.